Navigation Links
Bayer Creates Yaz Injury Settlement Fund of $1.5 Billion
Date:3/27/2013

Boca Raton, FL (PRWEB) March 27, 2013

Many women across the U.S. have experienced blood clotting-related health disorders after taking birth control medications Yaz, Yasmin or Ocella****. However, many injured women do not know that they may be entitled to financial compensation and that Bayer AG, the manufacturer of aforementioned birth control pills, created a fund of $1.5 Billion to deal directly with lawsuits associated with these drugs**. In order to ensure that patients have the best chance of collecting their portion of the fund, injured parties are encouraged to contact a law firm specializing in pharmaceutical product liability cases. As of January 2013, there were already over ten thousand reported case filings, and many industry insiders suspect that number will continue to grow**. A qualified attorney can assist those who have suffered injuries from using Yaz, Yasmin or Ocella, gain access to funds available only to those who file now.

Plaintiffs claim to suffer from a wide variety of Yaz side effects, such as blood clots, heart attacks, strokes and even death***. Some of the more serious reports surround injuries like DVT (deep vein thrombosis) and pulmonary embolism***.

According to the British Medical Journal and studies by the FDA, you have as much as a 74% greater chance of Yaz side effects such as DVT, strokes and blood clots after using the birth control drug*. It’s also reported that Bayer has already paid out an estimated billion dollars to settle lawsuits filed surrounding these new findings**. Because of the volume of cases being filed, the court proceedings have been consolidated to a special federal Multi-District Litigation court in the Southern District, Illinois. Due to the specialized nature of the federal drug litigations, patients are being urged to seek counsel with a Yaz lawsuit attorney that’s well versed in the case, now known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinios).

The most important goal of ongoing awareness programs is to identify and educate women who have experienced such problems, and not yet related them to birth control pills as being the alleged culprit. Friends and family members are being urged to get involved and encourage victims to contact a qualified Yaz lawsuit attorney to help them seek and attain financial compensation for their hardships.

Because so many potential victims have not yet heard of the recalls and may not be aware they too are entitled to a portion of the funds already set aside, time may be limited for those eligible to collect. As aggressive initiatives to inform the public continue, more and more women are coming forward to file legal action and to speak up to help spread the word about possible Yaz side effects, the health risks associated, and the financial compensation that may be due them.

The FDA letter to Bayer Pharmaceuticals was very critical of the lack of attention and focus placed on possible Yaz side effects and set the tone as early as November 2009 for what was to come***.

If you or a loved one was negatively affected by taking Yaz, Yasmin or Ocella, please visit http://yazsideeffects.com/ to learn about the serious blood clotting related side effects and consequent injuries.

Sources:
*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints
**Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013
***Bayer HealthCare - Bayer Schering Pharma AG 8/5/09, http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm182206.htm, August 5, 2009
**** Business Development and Legal Notes section, Bayer Interim Financial Statement, September 30, 2012.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10560284.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
2. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
3. Laser Die-Cutting Creates New Opportunities for Acrylic Photo Gifts
4. Hear This: 3-D Printing Creates Lifelike Artificial Ears
5. Skin Authority Creates One-of-a-Kind Solution for the One Billion People Worldwide Who are Vitamin D Deficient -- Groundbreaking Launch of "Inside Out" System
6. Unique Web Consulting Creates a New Website for Olive Dental Group
7. Long Island Trainer Sylvia Nasser Creates New Weight Loss and Fitness Program for the Modern Woman
8. Autism Speaks creates Delivering Scientific Innovation for Autism LLC
9. Scientist creates new cancer drug that is 10 times more potent
10. A CNIO team creates a unique mouse model for the study of aplastic anaemia
11. Team creates new view of bodys infection response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a ... (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the 90 ... their favorite way to cook a hot dog, far outpacing other cooking methods such ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: